Mycophenolate Mofetil

吗替麦考酚酯

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameMycophenolate Mofetil
Drug Alias NameME-MPA麦考酚酸吗乙酯Cellcept Capsules麦考酚酸莫酯MMF +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors
TargetsInosine-5'-monophosphate dehydrogenase (IMPDH)
Therapy Area/IndicationsRejection of organ transplantationRejection of renal transplantationRejection of lung transplantation +[56] 
Global Approved IndicationsRejection of organ transplantationRejection of renal transplantationRejection of liver transplantation +[4] 
Approved Indications in ChinaRejection of renal transplantation
Original Approved Country/TerritoryUnited States
Original Approved Date1995/05/03
Country/TerritoryFormer Serbia and MontenegroCzechiaBelgium +[48] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Food And Drug Safety Evaluation, KoreaChugai Pharmaceutical Co LtdSyntex Laboratories Inc +[9] 
Inactive CompaniesAugusta UniversityNational Institutes Of Health Clinical Center (Cc)Bristol Myers Squibb Srlcompany +[23] 
Active IndicationsRejection of organ transplantationRejection of renal transplantationScleroderma, Systemic +[9] 
Inactive IndicationsRejection of lung transplantationFastingStress, Psychological +[47] 

Other Information

ATC CodeL04AA06
Related LinksWikipediaDrugBankKEGG